At-Home HPV test could revolutionize screening for women with autoimmune conditions

NCT ID NCT06302725

Completed Diagnosis Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times

Summary

This study looks at whether women with immune-mediated inflammatory diseases (like lupus or Sjögren's syndrome) can use a vaginal self-sampling kit to check for high-risk HPV, the virus that can cause cervical cancer. Researchers will track 300 women aged 30-65 to see how many have HPV and if the self-test is acceptable. The goal is to make cervical cancer screening easier for those with chronic immune conditions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: vaginal self-sampling for HPV detection
What this could lead to: If successful, this could offer a more accessible and comfortable way for women with immune diseases to screen for cervical cancer.
What could go wrong: This is an observational study, not a treatment trial. It only measures HPV prevalence and screening uptake, so it won't directly improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV INFECTION SYSTEMIC DISEASE

Contacts and locations

Locations

Service de Médecine Interne - Hôpital Bichat Claude Bernard

Paris, 75018, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.